Detalles de la búsqueda
1.
Altered treatment of chronic lymphocytic leukemia in Germany during the last decade.
Ann Hematol
; 95(6): 853-61, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021305
2.
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
Antimicrob Agents Chemother
; 59(4): 2078-85, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25624327
3.
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ann Hematol
; 93(1): 13-32, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24026426
4.
Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.
Eur J Haematol
; 88(1): 68-77, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21883484
5.
Dying of hematologic patients--treatment characteristics in a German University Hospital.
Support Care Cancer
; 20(11): 2895-902, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22410860
6.
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
Mycoses
; 54(3): 230-3, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19889174
7.
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Haematologica
; 94(1): 113-22, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19066334
8.
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ann Hematol
; 88(2): 97-110, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18853161
9.
Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
Mycoses
; 52(2): 107-17, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18983431
10.
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
J Antimicrob Chemother
; 61(4): 939-46, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18272515
11.
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
Int J Hematol
; 87(2): 126-131, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18288564
12.
Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic study.
Leuk Res
; 37(8): 900-6, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23623559
13.
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Curr Med Res Opin
; 27(2): 335-42, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21155707
14.
Tuberculosis risk factors and mortality in patients with hematologic malignances.
Haematologica
; 90(8): 1014, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16079098
15.
Polymorphisms of CXCR3-binding chemokines in type 1 diabetes.
Hum Immunol
; 70(7): 552-5, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19410617
16.
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
Int J Antimicrob Agents
; 34(5): 446-50, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19700265
17.
TIM-3 polymorphisms in type 1 diabetes families.
J Hum Genet
; 53(6): 559-564, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18401547
18.
Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
Onkologie
; 30(4): 185-91, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17396041
19.
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
J Infect
; 55(5): 445-9, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17822770
20.
Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia.
Ann Hematol
; 84(11): 734-41, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15951986